March 13th, 2007, by Digital Davo | depression & anxiety, ocular rosacea
No real surprises here - this study finding that ocular rosacea affects sufferers’ quality of life. Quality of life impact of ocular rosacea, Tanya Dannemann, Medical College of Georgia, Augusta, GA, United States; Kimberly Nicholson, Emory University, Atlanta, GA, United States; Justin Estaris, Emory University, Atlanta, GA, United States; Suephy Chen, MD, MS, Emory University, Atlanta, GA, United States Many people with rosacea …
December 1st, 2006, by Digital Davo | ocular rosacea
This paper is interesting given that there is an ongoing clinical trial to look at restasis and treating ocular rosacea.
Current Treatment of Ocular Rosacea, Topical cyclosporine proves to be effective in treating rosacea. BY BARRY A. SCHECHTER, M.D.
Topical cyclosporine provided statistically significantly greater improvements in Schirmer scores (Graph 1), TBUT (Graph 2), corneal staining and ocular surface disease index (OSDI) scores (Graph 3) …
November 18th, 2006, by Digital Davo | ocular rosacea
Interesting preliminary statistical result that children with a style between the ages of 2-17 have a higher chance of developing ocular rosacea in adulthood. Steve, has posted this comment to rosacea-support, “Seems logical to me. I had a terrible problem with styes and chalazions when I was young, but had perfect skin until I hit 21. After that it was rosacea big time!”, also arteest103 says “This is …
July 25th, 2006, by Digital Davo | clinical trials, ocular rosacea
A clinical trial to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea is currently recruiting patients. The study is designed to compare the `efficacy of topical cyclosporin (Restasis) with that of Refresh Endura for the treatment of the signs and symptoms of ocular rosacea in patients presently controlled on topical corticosteroids’.The Inclusion criteria ;Pt at least 18 yrs …
May 17th, 2006, by Digital Davo | ocular rosacea, oracea, patents
So called low dose doxycycline, and treating rosacea has had some good research published in recent years. The treatment dose is low enough to not have antibiotic ability, but still give a therapeutic benefit. Tetracyclines have also been used successfully to treat ocular rosacea symptoms. This patent covers the ability to co-treat rosacea and ocular rosacea together.
One would think that such a patent would be …
|
|
|
|
|
|
|
|
|